King Luther Capital Management Corp Sells 23,386 Shares of Express Scripts (ESRX)

King Luther Capital Management Corp reduced its position in shares of Express Scripts (NASDAQ:ESRX) by 83.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,708 shares of the company’s stock after selling 23,386 shares during the quarter. King Luther Capital Management Corp’s holdings in Express Scripts were worth $325,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in the business. Bank of New York Mellon Corp increased its stake in shares of Express Scripts by 8.7% in the 4th quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock valued at $618,609,000 after acquiring an additional 666,754 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in shares of Express Scripts by 5.7% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 7,190,246 shares of the company’s stock valued at $496,703,000 after acquiring an additional 388,601 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Express Scripts by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock valued at $492,297,000 after acquiring an additional 32,548 shares during the last quarter. LSV Asset Management increased its stake in shares of Express Scripts by 3.4% in the 1st quarter. LSV Asset Management now owns 5,090,166 shares of the company’s stock valued at $351,628,000 after acquiring an additional 165,700 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its stake in shares of Express Scripts by 4.0% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 3,847,820 shares of the company’s stock valued at $286,701,000 after acquiring an additional 147,293 shares during the last quarter. 85.82% of the stock is owned by hedge funds and other institutional investors.

In related news, VP Everett Neville sold 4,895 shares of the stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total value of $368,397.70. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Christine Houston sold 19,889 shares of the stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total value of $1,525,287.41. The disclosure for this sale can be found here. Corporate insiders own 0.79% of the company’s stock.

Express Scripts opened at $76.52 on Tuesday, according to Marketbeat Ratings. The company has a market capitalization of $42.49 billion, a PE ratio of 10.78, a P/E/G ratio of 0.95 and a beta of 0.98. The company has a debt-to-equity ratio of 0.81, a current ratio of 0.69 and a quick ratio of 0.56. Express Scripts has a 12 month low of $55.80 and a 12 month high of $85.07.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Wednesday, May 2nd. The company reported $1.77 EPS for the quarter, beating the consensus estimate of $1.76 by $0.01. The company had revenue of $24.77 billion during the quarter, compared to the consensus estimate of $24.80 billion. Express Scripts had a return on equity of 25.41% and a net margin of 4.59%. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.33 EPS. sell-side analysts forecast that Express Scripts will post 9.07 earnings per share for the current year.

Several brokerages recently issued reports on ESRX. Barclays decreased their price objective on Express Scripts from $84.00 to $83.00 and set an “equal weight” rating for the company in a research report on Thursday, May 3rd. BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Tuesday. Sanford C. Bernstein downgraded Express Scripts from a “market perform” rating to an “underperform” rating and upped their price target for the stock from $55.80 to $77.50 in a research report on Tuesday, January 30th. Jefferies Group set a $91.00 price target on Express Scripts and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Finally, William Blair downgraded Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Thursday, March 8th. Four analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $82.50.

Express Scripts Company Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply